Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Hoof

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemiaM A Boogaerts, A Van Hoof, D Catovsky, et al.
Journal of Internal Medicine|June 25, 2009
Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric studyDaan Dierickx, G Verhoef, A Van Hoof, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-CurieJ Raemaekers, M Burgers, M Henry-Amar, et al.
Leukemia|October 29, 2004
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in "unmutated" B-CLLL Michaux, I Wlodarska, K Rack, et al.
British Journal of Haematology|May 1, 1997
Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 casesA Criel, G Verhoef, R Vlietinck, et al.
Blood|December 15, 1995
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of responseM Cazzola, D Messinger, V Battistel, et al.
Leukemia|March 20, 2009
Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemiaN Put, P Meeus, B Chatelain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Leukemia|February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasP Vandenberghe, I Wlodarska, L Michaux, et al.
Surgery Today|June 17, 2020
Long-term outcomes of major abdominal surgery and postoperative delirium after multimodal prehabilitation of older patientsTies L Janssen, Ewout W Steyerberg, Chantal C H A van Hoof-de Lepper, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemiaM A Boogaerts, A Van Hoof, D Catovsky, et al.
Journal of Internal Medicine|June 25, 2009
Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric studyDaan Dierickx, G Verhoef, A Van Hoof, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-CurieJ Raemaekers, M Burgers, M Henry-Amar, et al.
Leukemia|October 29, 2004
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in "unmutated" B-CLLL Michaux, I Wlodarska, K Rack, et al.
British Journal of Haematology|May 1, 1997
Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 casesA Criel, G Verhoef, R Vlietinck, et al.
Blood|December 15, 1995
Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of responseM Cazzola, D Messinger, V Battistel, et al.
Leukemia|March 20, 2009
Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemiaN Put, P Meeus, B Chatelain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Leukemia|February 20, 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemiasP Vandenberghe, I Wlodarska, L Michaux, et al.
Surgery Today|June 17, 2020
Long-term outcomes of major abdominal surgery and postoperative delirium after multimodal prehabilitation of older patientsTies L Janssen, Ewout W Steyerberg, Chantal C H A van Hoof-de Lepper, et al.
Pageof 7